Voorbeelden van het gebruik van Increased bleeding risk in het Engels en hun vertalingen in het Nederlands
{-}
-
Medicine
-
Colloquial
-
Official
-
Ecclesiastic
-
Financial
-
Computer
-
Ecclesiastic
-
Official/political
-
Programming
Neoplasm with increased bleeding risk.
rivaroxaban is not recommended in patients with an increased bleeding risk such as.
Neoplasm with increased bleeding risk.
Cangrelor should be used with caution in patients with disease states associated with an increased bleeding risk.
If you have an increased bleeding risk, as could be the case in the following situations.
Mensen vertalen ook
These patients may have an increased bleeding risk.
Due to the increased bleeding risk care is to be taken if patients are treated concomitantly with any other anticoagulants see section 4.4.
rivaroxaban is to be used with caution in patients with an increased bleeding risk such as.
Due to the increased bleeding risk care is to be taken if patients are treated concomitantly with any other anticoagulants see sections 4.3 and 4.4.
A coagulation test helps to identify patients with an increased bleeding risk due to increased dabigatran exposure.
Patients with an increased bleeding risk(see sections 4.4,
may help to identify patients with an increased bleeding risk caused by excessive dabigatran exposure.
pharmacodynamic effects of rivaroxaban which may lead to an increased bleeding risk.
A coagulation test helps to identify patients with an increased bleeding risk due to increased dabigatran exposure see sections 4.2,
Patients with increased bleeding risk(such as thrombocytopenia)
NSAIDs: NSAIDs given for short-term perioperative analgesia have been shown not to be associated with increased bleeding risk when given in conjunction with dabigatran etexilate.
which may lead to an increased bleeding risk.
is to be used with caution in patients with an increased bleeding risk such as:• congenital
rivaroxaban plasma levels may be significantly increased which may lead to an increased bleeding risk.
rivaroxaban plasma levels may be significantly increased which may lead to an increased bleeding risk.
therefore may increase rivaroxaban plasma concentrations to a clinically relevant degree which may lead to an increased bleeding risk see section 4.5.
with significant increases in pharmacodynamic effects which may lead to an increased bleeding risk.
with significant increases in pharmacodynamic effects which may lead to an increased bleeding risk.
Concomitant use of GPIIb/IIIa antagonists increases bleeding risk.
Certain herbal remedies may also increase bleeding risk.
GPIIb/ IIIa antagonists Concomitant use of GPIIb/ IIIa antagonists increases bleeding risk.
There is an increased risk of bleeding.
Post-surgical patients with an increased risk for bleeding.